- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
P3 Health Partners Inc (PIII)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/09/2026: PIII (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $10.25
1 Year Target Price $10.25
| 2 | Strong Buy |
| 0 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 242.76% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 688.66M USD | Price to earnings Ratio - | 1Y Target Price 10.25 |
Price to earnings Ratio - | 1Y Target Price 10.25 | ||
Volume (30-day avg) 4 | Beta 0.89 | 52 Weeks Range 3.25 - 14.50 | Updated Date 01/9/2026 |
52 Weeks Range 3.25 - 14.50 | Updated Date 01/9/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -57.16 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -9.07% | Operating Margin (TTM) -12.81% |
Management Effectiveness
Return on Assets (TTM) -20.85% | Return on Equity (TTM) -202.6% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 238389116 | Price to Sales(TTM) 0.48 |
Enterprise Value 238389116 | Price to Sales(TTM) 0.48 | ||
Enterprise Value to Revenue 0.17 | Enterprise Value to EBITDA -1.86 | Shares Outstanding 3268218 | Shares Floating 1243664 |
Shares Outstanding 3268218 | Shares Floating 1243664 | ||
Percent Insiders 62.09 | Percent Institutions 10.91 |
Upturn AI SWOT
P3 Health Partners Inc

Company Overview
History and Background
P3 Health Partners Inc. was founded in 2019 with the mission to transform primary care for Medicare Advantage beneficiaries. It has rapidly grown by partnering with independent physicians to integrate advanced technology and care management services, aiming to improve patient outcomes and reduce healthcare costs.
Core Business Areas
- Primary Care Services: P3 Health Partners provides comprehensive primary care services, focusing on chronic disease management, preventative care, and patient engagement for Medicare Advantage members.
- Care Management Technology: Leveraging proprietary technology platforms, P3 offers tools for data analytics, patient outreach, and care coordination to its affiliated physician practices.
- Value-Based Care Models: The company operates primarily within value-based care arrangements, aligning physician incentives with quality outcomes and cost containment.
Leadership and Structure
P3 Health Partners is led by a management team with experience in healthcare delivery and technology. The company partners with independent physician groups, providing them with operational and technological support rather than directly employing all physicians.
Top Products and Market Share
Key Offerings
- Description: A comprehensive suite of services and technology designed for primary care physicians serving Medicare Advantage patients. This includes data analytics for patient stratification, proactive outreach programs, and care coordination tools. Competitors include other primary care enablement platforms and large integrated health systems.
- Market Share Data: As a privately held company that partners with existing practices, specific market share data for this offering is not publicly available. However, P3 aims to capture a significant portion of the Medicare Advantage primary care market through its partnerships.
- Product Name 1: Integrated Primary Care Platform
Market Dynamics
Industry Overview
The US healthcare industry, particularly the Medicare Advantage sector, is experiencing significant growth driven by an aging population and a shift towards value-based care models. There's increasing demand for integrated care solutions that improve patient outcomes and manage costs effectively.
Positioning
P3 Health Partners is positioned as an enabler of value-based care for independent primary care physicians, offering them the tools and support needed to succeed in Medicare Advantage. Its competitive advantage lies in its integrated technology platform and focus on proactive, population health management.
Total Addressable Market (TAM)
The TAM for Medicare Advantage is substantial and growing, with millions of beneficiaries. P3 Health Partners is positioned to capture a segment of this market by partnering with physician groups, aiming to serve a growing number of eligible patients within its network. The exact TAM for P3's specific enablement services is difficult to quantify without public financials, but the underlying Medicare Advantage market is in the hundreds of billions of dollars.
Upturn SWOT Analysis
Strengths
- Focus on high-growth Medicare Advantage market
- Proprietary technology platform for care management
- Partnership model with independent physicians
- Emphasis on value-based care and outcomes
Weaknesses
- Reliance on physician partnerships, which can be subject to attrition
- Need for continuous investment in technology and talent
- Limited public financial transparency
- Building brand recognition in a competitive landscape
Opportunities
- Expansion into new geographic markets
- Development of new service lines or technologies
- Increased adoption of value-based care models by payers
- Partnerships with health insurance companies
Threats
- Regulatory changes in Medicare Advantage
- Competition from larger healthcare systems and other enablement platforms
- Challenges in physician recruitment and retention within partner practices
- Evolving healthcare reimbursement models
Competitors and Market Share
Key Competitors
- Oak Street Health (OSHC - delisted, acquired by CVS Health)
- Cano Health, Inc. (CANO)
- Agilon Health, Inc. (AGIL)
- CenterWell (part of Humana)
Competitive Landscape
P3 Health Partners competes in a dynamic market against established players and emerging innovators. Its focus on integrating technology with physician partnerships is a key differentiator, but it faces challenges from larger, more integrated health systems and companies with greater brand recognition and resources.
Growth Trajectory and Initiatives
Historical Growth: P3 Health Partners has demonstrated rapid growth since its inception in 2019, driven by its expansion of physician partnerships and patient enrollment within the Medicare Advantage population.
Future Projections: Future growth is expected to be driven by further expansion of its physician network, increased penetration within existing markets, and continued adoption of its technology and care management solutions. Specific analyst projections are not publicly available.
Recent Initiatives: Recent initiatives likely focus on deepening existing physician relationships, enhancing its technology platform, and potentially exploring strategic partnerships to expand its reach.
Summary
P3 Health Partners Inc. is a rapidly growing private company focused on transforming primary care for Medicare Advantage beneficiaries through technology and value-based care models. Its strengths lie in its specialized focus and innovative platform, while its weaknesses include reliance on partnerships and a lack of public financial transparency. The company has significant opportunities in the expanding Medicare Advantage market but faces threats from regulatory changes and strong competition. Continued strategic expansion and technological advancement will be crucial for its long-term success.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company website (p3hp.com)
- Industry reports on Medicare Advantage market
- News articles and press releases pertaining to P3 Health Partners Inc.
Disclaimers:
This information is based on publicly available data and may not be exhaustive. P3 Health Partners Inc. is a privately held company, and detailed financial and operational data is not publicly disclosed, which may limit the depth and accuracy of the analysis. This JSON output is for informational purposes only and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About P3 Health Partners Inc
Exchange NASDAQ | Headquaters Henderson, NV, United States | ||
IPO Launch date 2021-04-06 | CEO, President & Director Dr. Aric Coffman M.D. | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 360 | Website https://p3hp.org |
Full time employees 360 | Website https://p3hp.org | ||
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. The company operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

